• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Ethyl 3-bromo-2-methoxybenzoate (CAS No. 1106304-74-8): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ethyl 3-bromo-2-methoxybenzoate (CAS No. 1106304-74-8) is a significant compound in the realm of organic synthesis, particularly in the pharmaceutical industry. This ester derivative of benzoic acid boasts a unique structural framework that makes it a valuable intermediate in the synthesis of various bioactive molecules. The presence of both bromine and methoxy substituents on the aromatic ring endows it with distinct reactivity patterns, enabling its use in diverse chemical transformations.

The compound's molecular structure, characterized by a benzene ring substituted with a bromine atom at the 3-position and a methoxy group at the 2-position, along with an ethyl ester moiety, contributes to its versatility. This configuration allows for facile functionalization through nucleophilic aromatic substitution, cross-coupling reactions, and other palladium-catalyzed processes. Such reactivity is particularly useful in constructing complex molecular architectures essential for drug development.

In recent years, there has been growing interest in leveraging Ethyl 3-bromo-2-methoxybenzoate for the synthesis of novel therapeutic agents. For instance, researchers have explored its utility in generating derivatives with potential antimicrobial and anti-inflammatory properties. The bromine atom serves as an excellent handle for introducing further modifications via Suzuki-Miyaura or Stille couplings, enabling the construction of biaryl systems that are prevalent in many pharmacophores.

Moreover, the methoxy group enhances the compound's solubility and stability under various reaction conditions, making it an attractive candidate for large-scale synthesis. This characteristic is particularly important in industrial settings where reproducibility and yield optimization are paramount. Recent studies have demonstrated its effectiveness in multi-step syntheses leading to active pharmaceutical ingredients (APIs), underscoring its industrial relevance.

The pharmaceutical industry's demand for high-quality intermediates has driven innovation in synthetic methodologies involving Ethyl 3-bromo-2-methoxybenzoate. Advances in catalytic systems have enabled more efficient and environmentally benign routes to this compound, aligning with global trends toward sustainable chemistry. For example, recent developments in photoredox catalysis have opened new avenues for its preparation, offering greener alternatives to traditional methods.

Another area of interest is the use of Ethyl 3-bromo-2-methoxybenzoate in medicinal chemistry to develop small-molecule probes for biological target validation. Its structural features make it an ideal scaffold for generating libraries of compounds with tailored biological activities. Such libraries are instrumental in high-throughput screening (HTS) campaigns aimed at identifying lead compounds for further optimization.

The compound's role extends beyond classical pharmaceutical applications into materials science and agrochemicals. Its ability to undergo selective functionalization has been exploited in designing advanced materials with specific electronic properties. Additionally, derivatives of this compound have shown promise as intermediates in the synthesis of novel agrochemicals designed to enhance crop protection while minimizing environmental impact.

From a synthetic chemistry perspective, Ethyl 3-bromo-2-methoxybenzoate exemplifies the importance of heterocyclic compounds as building blocks. The benzoate ester not only provides a site for further derivatization but also influences the overall reactivity of the molecule. This duality makes it a powerful tool for chemists seeking to construct complex molecules with precise control over their properties.

In conclusion, Ethyl 3-bromo-2-methoxybenzoate (CAS No. 1106304-74-8) represents a cornerstone intermediate in modern synthetic chemistry. Its unique structural features and reactivity patterns make it indispensable for pharmaceutical research, materials science, and agrochemical development. As synthetic methodologies continue to evolve, this compound will undoubtedly remain at the forefront of innovation, driving advancements across multiple scientific disciplines.

• 1131587-93-3(Ethyl 5-bromo-2,4-diethoxybenzoate)
• 39503-51-0(Methyl 5-bromo-2,4-dimethoxybenzoate)
• 15790-59-7(Methyl 3,5-dibromo-2-methoxybenzenecarboxylate)
• 1131587-96-6(Methyl 4-(benzyloxy)-5-bromo-2-methoxybenzoate)
• 773136-05-3(Ethyl 5-bromo-2,4-dimethoxybenzoate)
• 90137-72-7(1,3-Benzenedicarboxylic acid, 5-bromo-4-methoxy-, dimethyl ester)
• 175204-91-8(Methyl 4,7-dibromo-3-methoxy-2-naphthoate)
• 773134-60-4(Ethyl 5-bromo-2-methoxybenzoate)
• 65977-12-0(Methyl 3-bromo-2,6-dimethoxybenzoate)
• 39503-52-1(Methyl 5-bromo-2-hydroxy-4-methoxybenzoate)